USPTO trademark

Alexion Pharmaceuticals, Inc design mark 7590248

RegisteredUSPTOFigurative markClass 5

"Design mark 7590248" is a figurative mark owned by Alexion Pharmaceuticals, Inc., filed at the USPTO on December 16, 2022. It is registered and covers class 5 (Pharmaceuticals).

View Alexion Pharmaceuticals, Inc. portfolio Get this data via the API

Data current as of December 3, 2024Official USPTO record

As filed with the USPTO

Status: Registered; Since December 3, 2024
Filed: December 16, 2022
Registered: December 3, 2024
Expires: Not recorded
Application no.: 97721298
Registration no.: 7590248
Office: USPTO; United States Patent and Trademark Office
Mark type: Figurative mark; 1 class

Ownership

Who owns Alexion Pharmaceuticals, Inc design mark 7590248

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Alexion Pharmaceuticals, Inc.

ALXN · Boston, United States

89 trademarks in the portfolioView company

Representative

Cara M. Kearney

AstraZeneca Pharmaceuticals LP

Goods and services

What the mark covers

The products and services Alexion Pharmaceuticals, Inc design mark 7590248 is filed for, grouped by Nice class.

05Class 5 · Pharmaceuticals
Pharmaceutical preparations for the treatment of hematological, nephrological, autoimmune, immunological, ocular, neurological and inflammatory related diseases and disorders

History

What has happened so far

Steps recorded by the USPTO, newest first.

December 3, 2024Notice of registration confirmation emailed
December 3, 2024Registered-principal register
October 22, 2024Notice of acceptance of statement of use e-mailed
October 22, 2024Allowed principal register - sou accepted
September 25, 2024Statement of use processing complete
September 23, 2024Case assigned to intent to use paralegal
July 23, 2024Use amendment filed
July 23, 2024Teas statement of use received
May 24, 2024Teas change of correspondence received
May 24, 2024Attorney/dom.rep.revoked and/or appointed

10 earlier steps on the official record.

FAQ

About Alexion Pharmaceuticals, Inc design mark 7590248

Who owns the trademark "Design mark 7590248"?

The USPTO trademark "Design mark 7590248" (application 97721298) is owned by Alexion Pharmaceuticals, Inc.

What is the status of "Design mark 7590248"?

Its status at the USPTO is: registered.

When was "Design mark 7590248" registered?

It was registered on December 3, 2024.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Alexion Pharmaceuticals, Inc design mark 7590248 and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2b35-dd4f-7059-85e9-67773007f795
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2b35-dd4f-7059-85e9-67773007f795",
  "object": "trademark",
  "mark_text": "[Design Mark]",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "97721298",
  "filing_date": "2022-12-16",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Alexion Pharmaceuticals, Inc.",
      "entity_id": "ent_019f285f-e3f1-77bc-bd2b-86a3120facbb"
    }
  ]
}